Catalog
Exposure to or harmful effects of undetermined intent of agents primarily affecting blood constituents
No MMS code
Link to WHO Definition
Exposure to or harmful effects of undetermined intent of agents primarily affecting blood constituents – http://id.who.int/icd/entity/1469250983
Parents
Children
- Exposure to or harmful effects of undetermined intent of iron or its compounds
- Exposure to or harmful effects of undetermined intent of immunosuppressive agents
- Exposure to or harmful effects of undetermined intent of other primarily systemic agents, not elsewhere classified
- Exposure to or harmful effects of undetermined intent of natural blood or blood products
- Exposure to or harmful effects of undetermined intent of other H1-receptor antagonists
- Exposure to or harmful effects of undetermined intent of thrombolytic drug
- Exposure to or harmful effects of undetermined intent of antineoplastic natural products
- Exposure to or harmful effects of undetermined intent of antithrombotic drugs
- Exposure to or harmful effects of undetermined intent of plasma substitutes
- Exposure to or harmful effects of undetermined intent of other fibrinolysis-affecting drugs
- Exposure to or harmful effects of undetermined intent of anticoagulant antagonists, vitamin K or other coagulants
- Exposure to or harmful effects of undetermined intent of anticoagulants
- Exposure to or harmful effects of undetermined intent of vitamin B12, folic acid or other anti-megaloblastic-anaemia preparations
- Exposure to or harmful effects of undetermined intent of antineoplastic antimetabolites
- Exposure to or harmful effects of undetermined intent of diphenhydramine
- Exposure to or harmful effects of undetermined intent of enzymes
- Exposure to or harmful effects of undetermined intent of other antineoplastic drugs
- Exposure to or harmful effects of undetermined intent of antiallergic or antiemetic drugs
- Exposure to or harmful effects of undetermined intent of acidifying or alkalising agents